## Bevel Secures $10M Series A from General Catalyst for AI Health Companion
Bevel, a burgeoning leader in health technology, has announced the successful closure of a $10 million Series A funding round led by prominent venture capital firm General Catalyst. This significant investment underscores growing confidence in Bevel’s innovative approach to personal health management.
The fresh capital will fuel the expansion and development of Bevel’s flagship AI health companion. This advanced platform leverages artificial intelligence to provide users with personalized health insights, proactive guidance, and tailored support, aiming to empower individuals in managing their well-being more effectively.
General Catalyst’s decision to lead the round highlights the increasing demand for intelligent, accessible, and preventative health solutions. The funding will enable Bevel to enhance its AI capabilities, expand its user base, and further solidify its position at the forefront of the digital health revolution, ultimately striving to make personalized health guidance a reality for many.